Abstract
We have studied the interactions of phosphodiester and phosphorothioate oligodeoxynucleotides with Mac-1 (CD11b/CD18; αMβ2), a heparin-binding integrin found predominately on the surface of polymorphonuciear leukocytes (PMNs), macrophages and natural killer cells. Binding of a homopolymer of thymidine occurred on both the αM and β2 subunits. Soluble fibrinogen, a natural figand for Mac-1, was an excellent competitor of the binding of a phosphorothioate oligodeoxynucleotide to both TNF-α-activated and nonactivated PMNs. Upregulation of cell-surface Mac-1 expression increased cell-surface binding of oligodeoxynucleotides. Binding was inhibited by anti-Mac-1 monoclonal antibodies, and the increase in cell-surface binding was correlated with a three- to fourfold increase in internalization by PMNs. An oligodeoxynucleotide inhibited β2-dependent migration through Matrigel, but the production of reactive oxygen species in PMNs adherent to fibrinogen dramatically increased. Thus, our data demonstrate that Mac-1 is a cell-surface receptor for oligodeoxynucleotides that can medi ate their internalization and that this binding may have important functional consequences.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Dean, N. & McKay, R. Inhibition of protein kinase C-α expression in mice after systemic administration of phosphorothioate antisense oligodeoxynucleotides. Proc. Notl. Acad. Sci. USA 91, 11762–11766 (1994).
Ratajczak, M. et al. In vivo treatment of human leukemia in a scid mouse model with c-myb antisense oligodeoxynucleotides. Proc. Natl. Acad. Set. USA 89, 11823–11827 (1992).
Cotter, F. et al. Antisense oligonucleotides suppress B-cell lymphoma growth in a SCID-hu mouse model. Oncogene 9, 3049–3055 (1994).
Shoji, Y. et al. Mechanism of cellular uptake of modified oligonucleotides containing methylphosphonate linkage. Nucleic Acids Res. 19, 5543–5550 (1991).
Yakubov, L.A. et al. Mechanism of oligonucleotide uptake by cells: Involvement of specific receptors?. Proc Natl. Acad. Sci. USA 86, 6454–6458 (1989).
Tonkinson, J.L. & Stein, C.A. Patterns of intra cellular compartmentalization, trafficking and acidification of 5′-fluorescein labeled phosphodiester and phosphorothioate oligodeoxynucleotides in HL60 cells. Nucleic Acids Res. 22, 4268–4275 (1994).
Loke, S.L. et al. Characterization of oligodeoxynucleotide transport into living cells. Proc. Natl. Acad. Sci. USA 86, 3474–3478 (1989).
Beltinger, C. et al. Binding, uptake and intracellular trafficking of phosphorothioate-modified oligodeoxynucleotides. J. Clin. Invest. 95, 1814–1823 (1995).
Rappaport, J. et al. Transport of phosphorothioate oligonucleotides in kidney: Implications for molecular therapy. Kidneyv Int. 47, 1462–1469 (1995).
Guvakova, M.A. et al. Phosphorothioate oligodeoxynucleotides bind to basic fi-broblast growth factor, inhibit its binding to cell surface receptors, and remove it from low affinity binding sites on extra Cellular matrix. J. Biol. Chem. 270, 2620–2627 (1995).
Kimura, Y. et al. Binding of oligoguanylate to scavenger receptors is required for oligonucleotides to augment NK Cell activity and induce IFN. J. Biochem. 116, 991–994 (1994).
Coombe, D., Watt, S.M. & Parish, C.R. Mac-1 (CD11b/CD18) and CD45 mediate the adhesion of hematopoietic progenitor cells to stromal cell elements via recognition of stromal heparan sulfate. Blood 84, 739–752 (1994).
Diamond, M., Alon, R., Alon, R., Quinn M. & Springer, T. Heparin is an adhesive ligand for the leukocyte integrin Mac-1 (CD11b/CD18). J. Cell Biol. 130, 1473–1482 (1995)
Loike, J. et al. CD11 c/CDI 8 on neutrophils recognizes a domain at the N terminus of the Aa chain of fibrinogen. Proc. Natl. Acad. Sci. USA 88, 1044–1048 (1991).
Wright, S. et al. Complement receptor type three (CD11 b/CDI 8) of human poly-morphonuclear leukocytes recognizes fibrinogen. Proc Natl. Acad. Sci. USA 85, 7734–7738 (1988).
Wright, S. et al. Identification of the C3bi receptor of human monocytes and macrophages by using monoclonal antibodies. Proc. Natl. Acad. Sci. USA 80, 5699–5703 (1983).
Diamond, M., Staunton, D., Marlin, S. & Springer, T. Binding of the integrin Mac-1 (CD11 b/CDI 8) to the third immunoglobulin-like domain of ICAM-1 (CD54) and its regulation by glycosylation. Cell 65, 961–971 (1991).
Alteri, D. & Edgington, T. The saturable high affinity association of factor X to ADP-stimulated monocytes defines a novel function of the Mac-1 receptor. J. Biol. Chem. 263, 7007–7015 (1988).
Loike, J. etal. Fibrin regulates neutrophil migration in response to interleukin 8 and LTB4, TNF or fMLP. J. Exp. Med. 181, 1763–1772 (1995).
Mohri, H. & Ohkubo, T. Fibrinogen binds to heparin: The relationship of the binding of other adhesive proteins to heparin. Arch. Biochem. Biophys. 303, 27–31 (1993).
Bates, E., Ferrante, A., Harvey, D. & Poulos, A. Polyunsaturated fatty acids increase neutrophil adherence and integrin receptor expression. J. Leukocyte Biol. 53, 420–426 (1993).
Diamond M. et al The I domain is a major recognition site on the leukocyte integrin Mac-1 (CD11b/CD18) for four distinct adhesion ligands. J. Cell Biol. 120, 1031–1043 (1993).
Yakubov, L. et al. Oligodeoxynucleotides interact with recombinant CD4 at multiple sites. J. Biol. Chem. 268, 18818–18823 (1993).
Higgins, K. et al. Antisense inhibition of the p65 subunit of NF-κB blocks tumorigenicity and causes tumor regression. Proc. Natl. Acad. Sci. USA 90, 9901–9905 (1993).
Cheng, Y. & Prusoff, W. Relationship between the inhibition constant and the concentration of inhibitor which causes 50% inhibition (ISO) of an enzymatic reaction. Biochem. Pharmacol. 22, 3099–3108 (1973).
Stein C.A. Suramin: A novel antineoplastic agent with multiple potential mechanisms of action. Cancer Res. 52, 2239–2248 (1993).
El Khoury, J. et al. Macrophages adhere to glucose-modified fibronectin and collagen IV via their scavenger receptors. J Biol. Chem. 269, 10197–10200 (1994).
Fraser, I., Hughes, D. & Cordon, S. Divalent cation-independent macrophage adhesion inhibited by monoclonal antibody to murin scavenger receptor. Nature 364, 343–346 (1993).
El Khoury J. et al. Scavenger receptor-meiated adhension of microglia to β-amyloid fibrils and secretion of reactive oxygen species. Nature 382, 716–719 (1996).
Fuortes, M., Jen, W. & Nathan, C. Adhesion-dependent protein tyrosine phosphorylation in neutrophils treated with tumor necrosis factor. J. Cell. Biol. 120, 777–784 (1993).
Zhou, L. et al. Differential ligand binding specificities of recombinant CD11b/CD18 integrin l-domain. J. Biol. Chem. 269, 17075–17079 (1994).
Lee, J., Riew, P., Arnaout, M. & Liddington, R. Crystal structure of the A domain from the a subunit of integrin CR3 (CD11 b/CDI 8). Cell 80, 631–638 (1995).
Stein C.A. et al. Dynamics of the internalization of phosphodiester oligodeoxynu cleotides in HL60 cells. Biochemistry 32, 4855–4861 (1993).
Krieg, A. et al. Uptake of oligodeoxyribonucleotides by lymphoid cells is heterogeneous and inducible. Antisense Res. Dev. 1, 161–171 (1991).
Zhao, Q. et al. Comparison of cellular binding and uptake of antisense phosphodi ester, phosphorothioate, and mixed phosphorothioate and methylphosphonate oligonucleotides. Antisense Res. Dev. 3, 53–66 (1993).
Zhao, Q. et al. Stage specific oligonucleotide uptake in murine bone marrow B-Cell precursors. Blood 84, 3660–3666 (1994).
Graham, I., Anderson, D., Holers, V.M. & Brown, E. Complement receptor 3 (CR3, Mac-1, Integrin aM (32, CD11 b/CDI 8) is required for tyrosine phosphorylation of paxillin in adherent and nonadherent neutrophils. J. Cell. Biol. 127, 1139–1147 (1994).
Loike, J., Somes, M. & Silverstein, S. Creatine uptake, metabolism, and efflux in human monocytes and macrophages. Am. J. Physiol. 251, C128135 (1986).
Cai, T. & Wright, S. Energetics of leukocyte integrin activation. J. Biol. Chem. 270, 14538–14365 (1995).
Stein, C.A., Subasinghe C., Shinozuka, K. & Cohen, J. . Physicochemical properties of phosphorothioate oligodeoxynucleotides. Nucleic Acids Res. 16, 3209–3221 (1988).
Sambrook J., Fritsch E. & Maniatis T. Molecular Cloning: A Laboratory Manual. 10.66 (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York, (1989).
Knorre, D., Vlassov, V., Zarytova, V. & Karpova, G. Nucleotide and oligonucleotide derivatives as enzyme and nucleic acid targeted irreversible inhibitors. Chemical aspects. Adv. Enzyme Regul. 24, 277–300 (1985).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Benimetskaya, L., Loike, J., Khaled, Z. et al. Mac-1 (CD11b/CD18) is an oligodeoxynucleotide-binding protein. Nat Med 3, 414–420 (1997). https://doi.org/10.1038/nm0497-414
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/nm0497-414
This article is cited by
-
Stroke-Induced Peripheral Immune Dysfunction in Vitamin D–Deficient Conditions: Modulation by Progesterone and Vitamin D
Molecular Neurobiology (2021)
-
Antisense oligonucleotides: the next frontier for treatment of neurological disorders
Nature Reviews Neurology (2018)
-
Reconstruction of Toll-like receptor 9-mediated responses in HEK-Blue hTLR9 cells by transfection of human macrophage scavenger receptor 1 gene
Scientific Reports (2017)
-
Protein Kinase C-α is a Critical Protein for Antisense Oligonucleotide-mediated Silencing in Mammalian Cells
Molecular Therapy (2016)
-
Brain Microglia and Microglial Markers
Neuroscience and Behavioral Physiology (2016)